# Analysis of Oncogenes in Intrahepatic Cholangiocarcinoma or Mixed Hepatocellular-Cholangiocarcinoma in Tumor Tissue Samples

> **NCT02762721** · — · COMPLETED · sponsor: **ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA)** · enrollment: 131 (actual)

## Conditions studied

- Intrahepatic Cholangiocarcinoma
- Mixed Hepatocellular Cholangiocarcinoma
- Cholangiocarcinoma

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02762721
- **Lead sponsor:** ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA)
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2016-06-06
- **Primary completion:** 2017-04-06
- **Final completion:** 2017-04-06
- **Target enrollment:** 131 (ACTUAL)
- **Last updated:** 2017-06-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02762721

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02762721, "Analysis of Oncogenes in Intrahepatic Cholangiocarcinoma or Mixed Hepatocellular-Cholangiocarcinoma in Tumor Tissue Samples". Retrieved via AI Analytics 2026-08-02 from https://api.ai-analytics.org/clinical/NCT02762721. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*